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ABSTRACT 
Objectives    To  study  prevalence  of  Sexually  Transmitted  Infections  (STIs  - 
symptomatic, clinical & laboratorial) & response to syndromic treatment in 
among STI groups. 
 
Design  Community based interventional study 
 
Setting    Rual  area-Parol  Primary  Health  Centre(PHC),  District  Thane, 
Maharashtra state. 
 
Poulation  Women of reproductive age groups 15 -45 years 
 
Methods  Community based interventional study, conducted among representative group of 415 women of 
reproductive age groups, by simple random sampling technique in Parol PHC, District Thane, Maharashtra 
state. All symptomatic & asymptomatic women were counseled for examination & investigations & given 
syndromic treatment. Follow-up done to assess impact of syndromic treatment.  
 
Main Outcome  Prevalence of STI symptomatically was 39%, clinically 32.3% & Laboratorial 26%. After 
syndromic treatment, prevalence of STIs has statistically significantly reduced 
 
Statistical Analysis  Z-test 
 
Results  Of the surveyed women (415), prevalence of STI symptomatically was 39%, clinically 32.3% & 
Laboratorial 26%. The most common presenting symptom was vaginal discharge (36.4%)  followed by 
Burning Micturition (24.7%), Vulval itching (17.3%), Lower abdominal pain (13%) & Genital ulcer (8.6%). 
Clinically, 55.2% women were diagnosed as cervicitis & 44.8% as PID. Laboratorial diagnosed STIs were - 
vaginal candidiasis 46.3%, Bacterial vaginosis 25%, Trichmoniasis 19.4 %, Genital Herpes 7.4% & HIV 1.9%. 
After syndromic treatment, prevalence of STIs has statistically significantly reduced. 
Conclusion: Syndromic Rx & health education can definitely reduce STIs.  
 
Keywords: Sexually Transmitted Infections, Syndromic Treatment, Rural area. 
 
INTRODUCTION 
STIs  are  a  major  global  cause  of  acute  illness, 
infertility, long term disability & death, with severe 
medical & psychological consequences for millions 
of  men,  women  &  infants.  WHO  estimated,  340 
million  new  cases  of  syphilis,  gonorrhoea, 
chlamydia  &  trichomoniasis  have  occurred 
throughout  the  world  in  1999  in  men  &  women 
aged 15-49 years
1. 
 
As  large  numbers  of  STIs  are  asymptomatic, 
moreover, only part of the symptomatic population 
seeks health care & even a smaller number of cases 
are reported. The social stigma usually associated 
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with STIs may result in people seeking care from 
alternative  providers  or  not  seeking  care  at  all. 
However symptomatic & asymptomatic infections 
can  lead  to  the  development  of  serious 
complications  with  severe  consequences  for  the 
individuals &  community.  In  developing  countries 
STIs & their complications are amongst the top five 
disease  categories  for  which  adults  seek  health 
care
2.  Apart  from  being  serious  diseases  in  their 
own right; STIs enhance sexual transmission of HIV 
infection.  The  presence  of  untreated  STIs  can 
increase the risk of both acquisition & transmission 
of HIV by a factor of up to 10
3. 
 
The scale of STI problem is too great to be dealt 
with in specialized STI centres alone & steps must 
be taken to expand & integrate STI management in 
primary  &  other  health  facilities.  But  due  to  low 
literacy  level,  limited  exposure  to  mass  media  & 
interpersonal  communication,  rural  reproductive 
population  has  a  very  poor  perception  of  their 
sexual  health  &  sexual  health  needs.  Absence  of 
female service providers, lack of privacy & distance 
inhibit women from seeking treatment. Hence, it is 
important  to  provide  accessible  STI  services  at 
community level. 
  
However,  most  of  the  Indian  studies  on 
reproductive  health  of  women  have  been 
conducted at hospitals & in clinical setting such as 
STI  or  antenatal  clinic.  The  main  problem  in 
conducting  the  community-based  study  in  rural 
India  is  its  feasibility  &  accessibility  to  the 
population in need.  
 
Similarly many low-income countries with limited 
laboratory services, especially in rural areas, have 
adopted  syndromic  treatment  of  STIs.  With  this 
approach  patients  are  treated  on  the  basis  of 
groups  of  symptoms  &  signs  (syndromes)  rather 
than by identifying specific STI pathogens. 
 
Taking into consideration all above factors, study 
was conducted in rural area of Thane district which 
includes prevalence of STIs, speculum examination, 
investigations & syndromic treatment. 
 
 
METHODS 
The  present  community  based,  interventional 
study, was carried out over duration of 12 months, 
among women of reproductive age group, in rural 
area-Parol  Primary  Health  Centre  (PHC),  District 
Thane, Maharashtra state, affiliated to Department 
of  PSM  of  Topiwala  National  Medical  College 
(TNMC)  &  B.  Y.  L.  Nair  Ch.  Hospital,  Mumbai. 
Verbal  permission  was  taken  from  the  Head  of 
Department  of  Preventive  &  Social  Medicine  for 
conducting study. Parol PHC has 7 sub centres, 17 
villages  &  total  population  of  20,586,  which 
includes 4150 women in reproductive age group. A 
pilot  study  was  carried  out  among  65  married 
women of reproductive age group (50% of eligible 
couple  population  of  one  of  the  selected  village) 
wherein,  the  prevalence  of  STI  was  found  to  be 
49%. Taking into consideration the prevalence of 
STI  obtained  in  the  pilot  study  &  10%  allowable 
error,  the  estimated  study  sample  size  was  416. 
These  women  were  selected  by  stratified 
systematic  simple  random  sampling  method  of 
which one woman refused for interview in spite of 
counselling hence constituting sample size of 415 
for the study. Stratification was done at village level 
&  women  were  selected  from  each  village 
according to proportional allocation. For selection 
of  household  in  the  village,  first  we  calculated 
sampling  interval  by  dividing  total  population  by 
sample  size.  After  calculating  sampling  interval, 
first house was selected randomly & than sampling 
interval added to that random number to get desire 
number  of  women  in  each  village.  The  verbal 
consent was taken before collecting data from the 
women who were included in the present study.   
 
The household survey was carried out among study 
group  to  reveal  their  socio  demographic 
characteristics,  reproductive  history,  clinical 
symptoms regarding reproductive tract, treatment-
seeking history & sexual behaviour. At the end of 
interview,  list  of  symptomatic  &  asymptomatic 
women willing for syndromic treatment was given 
to the Auxiliary Nurse Midwife (ANM) & Anganwadi 
worker of respective village, so that they can bring 
women to  sub centre on the day of examination 
decided  for  clinical  examination  &  various 
investigations.  The  symptomatic  &  asymptomatic 
women along with their partners were then given 
syndromic treatment as per National AIDS Control 
Organization guidelines. The follow up & post test 
counselling  was  done  after  seven  days  at  the 
respective  sub  centre,  to  see  whether  she  has 
relieved  of  her  symptoms.  If  not,  she  was  given  
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drugs again for seven days to complete full course 
of 14 days.  
 
CONCEPTUAL FRAMEWORK 
Total population of PHC (rural area) (20,586) 
 
Total  population  of  women  of  reproductive  age 
group – 4150 
 
 Based on STI prevalence obtained in the pilot study 
i.e.  49%  &  10%  allowable  error-  sample  size 
calculated using 4PQ/L
2 i.e. 415 who were selected 
by stratified systematic simple random sampling 
 
Stratification  was  done  at  village  level  &  women 
were  selected  from  each  village  according  to 
proportional allocation  
 
Sample  population  was  then  selected  from  each 
village  by  systematic  simple  random  sampling 
method  to  identify  women  of  reproductive  age 
group to screen women for STI symptoms  
 
Symptomatic  &  asymptomatic  women  were 
counselled  for  examination  (per  speculum)  & 
investigations (Gram stain,  Ph, VDRL,  HIV  &  Pap 
smear screening) 
 
*Syndromic treatment of STI under supervision of 
Auxiliary Nurse Midwife 
 
 *The camps for syndromic treatment of STI were held at 
sub centre & PHC depending on the feasibility. In camp, 
woman  first  counselled  regarding  her  symptoms  & 
investigations to be done & verbal consent was obtained in 
all  cases.  With  due  respect  &  privacy,  speculum 
examination was done & specimen collected for ph testing, 
saline  wet  mount,  Gram  stain  &  Pap  smear  &  blood 
collection for VDRL & HIV. The specimens were taken to 
rural hospital for testing.  
 
The laboratory tests used are as follow:  
Vaginal  pH  testing:    determined  by  dipping  pH 
paper  into  the  discharge  present  on  vaginal 
speculum. 
Amine test: done by adding drop of 10% KOH on 
vaginal  discharge  taken  on  a  clean  microscopic 
slide.
 
Gram-staining: Pap smear: to detect Gonorrhoea, 
BV, vaginal candidiasis & early neoplastic changes. 
 
 
Diagnostic criteria used to define STIs: 
CLINICALLY DIAGNOSED STIs  
1.Cervicitis
4               Cervical erosion with purulent discharge from cervix 
2.PID
4  Adnexal tenderness &/or presence of tender adnexal  mass on 
bimanual pelvic examination 
LABORATORY- DIAGNOSED  RTIs 
1. Syphilis
5 
a. Current infection 
b. Past infection            
 
Positive serology by RPR test. 
Positive  result  on  Treponema  pallidum  particle  agglutination 
test.                                                  
2. Gonorrhoea
6 
 
Identification  of  gram  negative    intracellular  diplococci  in  Gm 
stained cervical smear 
3.Bacterial vaginosis
7,8 
AMSEL  
CRITERIA  
Presence of at least three of the following:  
 (a) watery vaginal discharge,   
 (b) elevated pH (>6),  
 (c) positive amine odor test,  
 (d) presence of clue cells in Gram-stained vaginal smear                                                     
4.Trichomoniasis
9  pH > 5.5
  
5.Vaginal Candidiasis
10                  Presence  of  clinical  signs  (red,  inflamed  tissue  &  curdy  white 
discharge) + Gm positive yeast bodies 
OTHER GYNECOLOGIC CONDITIONS 
Infertility
4  Inability to  conceive after two years of sexual activity  without 
contraception in a couple trying to conceive based on history.                                     
The data was analyzed & then compared with various studies done previously & presented in the form of tables & graphs 
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RESULTS 
Knowledge of STI was very low in all aspects while 
almost > 50% women had heard about HIV & nearly 
50%  women  knew  about  its  transmission  & 
preventive  modes.  86.7%  women  had  knowledge 
about  contraceptive  methods  though  the  use  of 
contraceptive  methods  was  comparatively  low 
(54.2%) (Table 1).  
 
 
 
 
 
 
 
Table 1 Knowledge, attitude & Practices of study  group regarding STI, HIV & contraception (N=415) 
 
 
 
 
 
 
 
 
Knowledge of STI  No.  % 
Heard  114  27.5 
Mode  of STI transmission   94  22.7 
Symptoms  69  16.6 
Curable  84  20.2 
Prevention Modes  85  20.5 
Knowledge of HIV/AIDS  No.  % 
Heard of HIV/AIDS  225  54.2 
Mode of HIV transmission   205  49.4 
Prevention  203  48.9 
Knowledge of Family Planning  No.  % 
Heard of FP Methods  360  86.7 
Currently Using any method  225  54.2 
Knowledge of STI  No.  % 
Heard  114  27.5 
Mode  of STI transmission   94  22.7 
Symptoms  69  16.6 
Curable  84  20.2 
Prevention Modes  85  20.5 
Knowledge of HIV/AIDS  No.  % 
Heard of HIV/AIDS  225  54.2 
Mode of HIV transmission   205  49.4 
Prevention  203  48.9 
Knowledge of Family Planning  No.  % 
Heard of FP Methods  360  86.7 
Currently Using any method  225  54.2  
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Table 2 Different STIs diagnosed symptomatically, clinically & by laboratory 
Total Surveyed women = 415 
SYMPTOMATICALLY  DIAGNOSED STIs (N=162)  No.  % 
Vaginal Discharge (VD)  59  36.4%  
Burning Micturition (BM)  40  24.7%  
Vulval itching (VI)  28  17.3% 
Lower abdominal pain (LAP)  21  13.0%  
Genital ulcer (GU)  14  08.6% 
Total  162  100% 
CLINICALLY DIAGNOSED STIs (N=134)  No.  % 
1.  Cervicitis  74   55.2% 
2.  PID  60  44.8% 
Total  134  100% 
LAB. DIAGNOSED STIs (N=108)  No.  % 
1.  Syphilis  00  0% 
2.  Gonorrhea  00  0% 
3.  Vaginal candidiasis  50  46.3% 
4.  Bacterial vaginosis  27  25.0% 
5.  Trichmoniasis  21  19.4% 
6.  Genital Herpes  08  07.4% 
7.  HIV  02  01.9% 
Total  108  100% 
OTHER GYNEC. CONDITIONS   No.  % 
1.  Infertility  17  4.1% 
 
The prevalence of STI symptomatically, clinically & 
by  laboratorial  method  was  39%,  32.3%,  &  26% 
respectively (Fig. 1). Among the women who were 
presenting  symptomatically,  the  most  common 
presenting  symptom  was  vaginal  discharge 
(36.4%),  followed  by  burning  micturition  (24.7%), 
vulval itching (17.3%), lower abdominal pain (13.0%) 
& least common was genital ulcer (8.6%). Clinically 
cervicitis  was  present  in  55.2%  &  Pelvic 
Inflammatory Disease in 44.8%. The most common 
laboratorial  STI  was  vaginal  candidiasis  in  46.3% 
women & least common HIV in 1.9%. (Table 3) 
 
 
Figure 1 Prevalence of Symptomatic, clinical & lab. Confirmed STIs (N=415)  
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Table 3 Outcome assessment of STIs 
STIs  Cured  Improved  Rx failure 
GU  size  reduction  of 
90% /  > 
50–90% reduction  Still  50%  /  >  in  size  than  it 
was at enrolment.  
Genital 
Discharge 
no  symptoms  / 
discharge 
reduction  in  symptoms 
& discharge 
No improvement 
BM, VI, LAP  no symptoms  reduction in symptoms  No improvement 
Cervicitis  size  reduction  of 
90%  /  >  &  no 
discharge 
50–90%  reduction  in 
size  &  reduction  in 
discharge 
No improvement 
PID  adnexal  tenderness 
&/or  presence  of 
tender adnexal mass 
on  bimanual                     
pelvic examination 
-  No improvement 
 
Treatment & follow up  
Table No. 4 gives assessment criteria for STIs after 
treatment.  Those  who  were  diagnosed  as  STI 
(symptomatically,  clinically  &  by  laboratory 
method),  treatment  was  provided  to  them 
according  to  national  guidelines  for  STI 
treatment
15.
  After  one  week,  follow  up 
questionnaire was administered asking participants 
about  any  current  symptoms  followed  by  clinical 
examination done to look for further signs of ulcers 
&  discharge.  Outcome  assessment  of  STIs  was 
made by clinician (Table 4). In cases of treatment 
failure second line treatment was given after seven 
days. Participants not returning for FU were visited 
at  home.  A  field  worker  administered  a 
questionnaire,  but  did  not  perform  a  clinical 
examination.  The  field  worker  recorded  patient’s 
self-assessment  of  cure,  whether  they  had  fully 
complied  with  the  medication,  any  current 
symptoms, & reasons for not returning for their FU 
visit.  
 
Table 4 Proportion of pre-syndromic & post-syndromic treatment groups 
Groups of STIs  Pre-syndromic 
Rx % (No.) 
Post-syndromic 
Rx % (No.) 
S.E.  Z  significance 
Symptomatic   39% (162)        14% (58)  3.0  8.3  S 
Clinical   32.3% (134)  9.4% (39)  2.7  8.5  S 
Lab.   26% (108)  9.6% (40)  2.6  6.3  S 
 
It was observed that after syndromic treatment - 
Symptomatic, clinical & lab prevalence of STIs has 
statistically significantly reduced from 39% to 14%, 
32.3% to 9.4%, and 26% to 9.6% respectively.  
 
DISCUSSION  
In the present study, knowledge of STI was very low 
in all aspects compared to HIV knowledge (mode of 
transmission & preventive measures). The present 
study reveals that in spite of significant awareness 
about family planning methods i.e. 86.7% only few 
women were (54.2%) using contraception. Similar 
findings  were  observed  by  Nikhilesh  Parchure, 
wherein knowledge about STI was low compared 
HIV/AIDS
11. The prevalence of STI symptomatically 
was 39%, those who diagnosed as STI clinically was 
32.3% & those confirmed on laboratory was 26%. In 
a study done by Monika Rathore, prevalence of STIs 
symptomatically  was  55%  &  clinically  61%
12.  
Among  symptomatically  diagnosed  STIs,  most  
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common  presenting  symptom  was  vaginal 
discharge  (36.4%)  &  least  common  was  Genital 
Ulcer  (8.6%).  Those  who  were  diagnosed  by 
clinically  STI  -  cervicitis  was  present  in  55.2%  & 
Pelvic  Inflammatory  Disease  in  44.8%.The  most 
common laboratorial STI was vaginal candidiasis in 
46.3% women & least common HIV in 1.9%. In a 
study  by S  C  Panda  et  al,  prevalence  of  STI  was 
39.2% {rural (44%); urban (32%)}. The commonest 
STI symptom was vaginal discharge (91%) followed 
by  lower  abdominal  pain  (64%),  backache  (76%), 
vulval itching (51%) & burning micturition (34%)
13. 
In a study done by Singh MM, prevalence of specific 
infections  were:  vaginitis  -  52.1%,  trichomoniasis 
(29.2%), candidiasis (22.9%), cervicitis -20.8%, PID 
(14.6%), combined Urinary Tract Infections & Pelvic 
Inflammatory Disease (4.2%)
14.  
 
CONCLUSION  
In the present study, prevalence  of symptomatic, 
clinical  &  laboratorial  diagnosed  STIs  among  was 
quite  high.  This  was  significantly  reduced  by 
syndromic  Rx  of  STIs  as  per  NACO  guidelines  if 
followed properly as per guidelines. Hence in rural 
area,  to  reduce  STIs,  NACO  guidelines  for 
syndromic  Rx  &  health  education  to  create 
awareness  of  STIs  &  to  motivate  rural women  in 
treatment seeking should be adopted consistently. 
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